An appropriate DNA input for bisulfite conversion reveals LINE-1 and Alu hypermethylation in tissues and circulating cell-free DNA from cancers
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0316394 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Trang Thi Quynh Tran und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biology, VNU University of Science, Vietnam National University, Hanoi, Vietnam. Hauptthemen laut MEDLINE: DNA Methylation, Long Interspersed Nucleotide Elements, Alu Elements, Sulfites. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Quỹ Đổi mới sáng tạo Vingroup.
Abstract (Originalsprache)
The autonomous and active Long-Interspersed Element-1 ( LINE-1 , L1 ) and the non-autonomous Alu retrotransposon elements, contributing to 30% of the human genome, are the most abundant repeated sequences. With more than 90% of their sequences being methylated in normal cells, these elements undeniably contribute to the global DNA methylation level and constitute a major part of circulating-cell-free DNA (cfDNA). So far, the hypomethylation status of LINE-1 and Alu in cellular and extracellular DNA has long been considered a prevailing hallmark of ageing-related diseases and cancer. This study demonstrated that errors in LINE-1 and Alu methylation level measurements were caused by an excessive input quantity of genomic DNA used for bisulfite conversion. Using the minuscule DNA amount of 0.5 ng, much less than what has been used and recommended so far (500 ng-2 μg) or 1 μL of cfDNA extracted from 1 mL of blood, we revealed hypermethylation of LINE-1 and Alu in 407 tumour samples of primary breast, colon and lung cancers when compared with the corresponding pair-matched adjacent normal tissue samples (P < 0.05–0.001), and in cfDNA from 296 samples of lung cancers as compared with 477 samples from healthy controls (P < 0.0001). More importantly, LINE-1 hypermethylation in cfDNA is associated with healthy ageing. Our results have not only contributed to the standardized bisulfite-based protocols for DNA methylation assays, particularly in applications on repeated sequences but also provided another perspective for other repetitive sequences whose epigenetic properties may have crucial impacts on genome architecture and human health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Biology, VNU University of Science, Vietnam National University, Hanoi, Vietnam.
- VNU Institute of Microbiology and Biotechnology, Hanoi, Vietnam.
- Department of Chemistry, 175 Hospital, Ho Chi Minh City, Vietnam.
- Pathology and Molecular Biology Center, Vietnam National Cancer Hospital, Hanoi, Vietnam.
- Endoscopic Centre, Hanoi Medical University Hospital, Hanoi, Vietnam.
- Institute of Biomedicine and Pharmacy, Ha Dong, Vietnam.
ORCID-Profile: Lan Thi Thuong Vo
Förderung
- Quỹ Đổi mới sáng tạo Vingroup
Zitieren
APA
Tran, T. T. Q., Pham, T. T., Nguyen, T. T., Hien Do, T., Luu, P. T. T., Nguyen, U. Q., Vuong, L. D., Nguyen, Q. N., Ho, S. V., Dao, H. V., Hoang, T. V., & Vo, L. T. T. (2024). An appropriate DNA input for bisulfite conversion reveals LINE-1 and Alu hypermethylation in tissues and circulating cell-free DNA from cancers. PLOS ONE. https://doi.org/10.1371/journal.pone.0316394
Vancouver
Tran TTQ, Pham TT, Nguyen TT, Hien Do T, Luu PTT, Nguyen UQ, et al. An appropriate DNA input for bisulfite conversion reveals LINE-1 and Alu hypermethylation in tissues and circulating cell-free DNA from cancers. PLOS ONE. 2024. doi:10.1371/journal.pone.0316394
BibTeX
@article{Tran2024,
author = {Tran, Trang Thi Quynh and Pham, Tung The and Nguyen, Than Thi and Hien Do, Trang and Luu, Phuong Thi Thu and Nguyen, Uyen Quynh and Vuong, Linh Dieu and Nguyen, Quang Ngoc and Ho, Son Van and Dao, Hang Viet and Hoang, Tong Van and Vo, Lan Thi Thuong},
title = {An appropriate DNA input for bisulfite conversion reveals LINE-1 and Alu hypermethylation in tissues and circulating cell-free DNA from cancers},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0316394}
}
EUVIMED